Cholesterol results make most sense as part of your overall cardiovascular risk, not as a single number labelled good or bad. Ask the GP which lipid measurements are reported, whether you need treatment and what target applies personally. I would keep the full report, units and earlier results together. A general healthy range and a treatment goal after a heart attack are different reference points, so do not treat every laboratory flag as the same decision.
1. Which numbers are in my cholesterol results?
A lipid profile can report total cholesterol, HDL, non-HDL, LDL and triglycerides. Non-HDL is calculated by subtracting HDL from total cholesterol and includes several potentially harmful cholesterol-carrying particles. LDL is one component, while triglycerides are another type of blood fat.
Ask what the laboratory actually measured or calculated and read the units. If you have results from another provider, bring the full report so differences in units and treatment timing can be properly checked. UK results usually use mmol/L; figures from another country may use a different unit. A number copied from Hull Report cannot be compared safely without knowing what it represents.
The total-to-HDL ratio helps risk assessment but does not explain everything. A reassuring ratio can coexist with raised non-HDL or LDL, so it should not automatically override the rest of the profile.
2. Are these general ranges or my treatment targets?
NHS general guidance gives total cholesterol below 5 mmol/L and non-HDL below 4 mmol/L as healthy levels for adults. HDL is generally above 1.0 mmol/L for men or 1.2 mmol/L for women. These are not universal personalised targets.
For people with established cardiovascular disease, NICE recommends lower treatment thresholds: LDL of 2.0 mmol/L or less, or non-HDL of 2.6 mmol/L or less. The aim is to reduce future events, not merely remove a flag from the laboratory display.
Ask which category applies and why. Age, existing conditions and treatment history can change the interpretation without changing the number printed on the report.
3. How does the GP assess my overall risk?
The discussion can include age, blood pressure, smoking, diabetes, kidney disease, family history and previous cardiovascular events. People without established disease may have a risk estimate to support decisions about prevention.
Cholesterol is one part of that picture. A public article at coventryinsight.co.uk cannot calculate your risk from one lipid value. Ask the clinician to explain the factors, uncertainty and expected benefit of recommended treatment in understandable terms.
Very high cholesterol or a strong history of early heart disease can suggest inherited problems. Mention close relatives’ diagnoses and ages where known; being active or slim does not exclude an inherited lipid condition.
4. Does it matter that I had eaten?
Routine lipid profiles do not generally require fasting. However, triglycerides and particular clinical questions can lead to a fasting repeat. Follow the instructions for your own test rather than assume that eating breakfast invalidates every result.
Tell the GP about recent illness, important medicine changes and the circumstances of the sample. Ask whether a repeat is necessary and what preparation is required. Avoid arranging repeated private tests simply to search for a more reassuring number.
5. What changes or medicines would help?
Discuss diet, activity, smoking and other risk factors alongside whether a statin or another medicine is appropriate. Ask what benefit is expected and how side effects or interactions would be managed. Lifestyle support and medication are not automatically competing choices.
Keep the agreed plan distinct from general reading at Plymouth Wire. Do not stop an existing statin or substitute a supplement without clinical advice. A different formulation or treatment plan may be possible if problems occur.
6. When should we repeat the test?
NICE recommends a full lipid profile and liver transaminase test two to three months after starting or changing lipid-lowering treatment. For primary prevention, the target is usually a greater than 40% reduction in non-HDL cholesterol from baseline.
Ask who books the blood test and explains the response. If the target is not met, discuss treatment use, tolerability and next steps rather than changing the dose yourself. Finish with the actual goal, date and responsible team recorded.
This article provides general information, not an individual diagnosis or treatment plan; follow advice from your healthcare team and seek appropriate help for concerning symptoms.
